×
About 45,702 results

ALLMedicine™ Papillomavirus Center

Research & Reviews  21,331 results

Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of A...
https://doi.org/10.1177/0194599821989637
Otolaryngology--head and Neck Surgery : Official Journal ... Yan F, Li H et. al.

Feb 23rd, 2021 - Pathologic extranodal extension (ENE) is an important adverse feature for human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC), but the prognostic significance of microscopic ENE (ENEmi) and role of adjuvant concurrent...

Independent association of marijuana use and poor oral hygiene with HPV-negative but no...
https://doi.org/10.1002/cncr.33440
Cancer Shewale JB, Pickard RKL et. al.

Feb 23rd, 2021 - Sexual behavior is associated with human papillomavirus (HPV)-positive head and neck cancer, whereas tobacco and alcohol use are associated with HPV-negative cancer. A case-control study was designed to investigate additional demographic and behav...

Significant Declines in Juvenile Onset Recurrent Respiratory Papillomatosis following H...
https://doi.org/10.1093/cid/ciab171
Clinical Infectious Diseases : an Official Publication Of... Meites E, Stone L et. al.

Feb 23rd, 2021 - Juvenile onset recurrent respiratory papillomatosis (JORRP) is a rare and serious disease caused by human papillomavirus (HPV) presumably acquired during vaginal delivery. HPV vaccination of females through age 26 years, recommended in the United ...

Comparing Outcomes for Patients with Human Papillomavirus (HPV) Type 16 versus Other Hi...
https://doi.org/10.1016/j.semarthrit.2020.10.001
Head and Neck Pathology; Shenker RF, May NH et. al.

Feb 22nd, 2021 - The most efficacious strategy to manage pregnant patients with antiphospholipid syndrome (APS) refractory to conventional heparin/low-dose aspirin treatment or at high risk of adverse pregnancy outcomes has not been determined with any degree of c...

Evolution of Public Health Human Papillomavirus Immunization Programs in Canada.
https://doi.org/10.3390/curroncol28010097
Current Oncology (Toronto, Ont.); Goyette A, Yen GP et. al.

Feb 22nd, 2021 - Background: Since 2007, all Canadian provinces and territories have had a publicly funded program for vaccination against human papillomavirus (HPV) infection. The objective of this study was to describe the evolution of these vaccination programs...

see more →

Guidelines  65 results

ASCCP Risk-Based Colposcopy Recommendations Applied in Thai Women With Atypical Squamou...
https://doi.org/10.1097/AOG.0000000000003982
Obstetrics and Gynecology; Phianpiset R, Ruengkhachorn I et. al.

Aug 9th, 2020 - To compare the proportion of cervical intraepithelial neoplasia (CIN) 2 or worse pathology among different risk strata according to the ASCCP when applied in women who had atypical squamous cells of undetermined significance (ASC-US) or low-grade ...

Human Papillomavirus Vaccination: ACOG Committee Opinion, Number 809.
https://doi.org/10.1097/AOG.0000000000004000
Obstetrics and Gynecology;

Jul 31st, 2020 - Human papillomavirus (HPV) causes significant morbidity and mortality in women and men. The HPV vaccine significantly reduces the incidence of anogenital cancer and genital warts in women and in men. Human papillomavirus vaccines are among the mos...

Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideli...
https://doi.org/10.3322/caac.21616
CA: a Cancer Journal for Clinicians References; Saslow D, Andrews KS et. al.

Jul 8th, 2020 - The American Cancer Society (ACS) presents an adaptation of the current Advisory Committee on Immunization Practices recommendations for human papillomavirus (HPV) vaccination. The ACS recommends routine HPV vaccination between ages 9 and 12 years...

European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncolog...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418593
International Journal of Gynecological Cancer : Official ... Ciavattini A, Delli Carpini G et. al.

Jun 3rd, 2020 - European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncology (ESGO) joint considerations about human papillomavirus (HPV) vaccination, screening programs, colposcopy, and surgery during and after the COVID-19 pandemic.|...

Transoral Resection Followed by Low-Dose Radiation for Some Oropharyngeal Cancers
https://ascopost.com/news/may-2020/transoral-resection-followed-by-low-dose-radiation-for-some-oropharyngeal-cancers/

May 29th, 2020 - The final results of the randomized phase II ECOG-ACRIN E3311 trial were presented by Robert L. Ferris, MD, PhD, and colleagues during the ASCO20 Virtual Scientific Program (Abstract 6500) and in today's Head and Neck Cancer Oral Abstract Session....

see more →

Drugs  7 results see all →

Clinicaltrials.gov  22,835 results

Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of A...
https://doi.org/10.1177/0194599821989637
Otolaryngology--head and Neck Surgery : Official Journal ... Yan F, Li H et. al.

Feb 23rd, 2021 - Pathologic extranodal extension (ENE) is an important adverse feature for human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC), but the prognostic significance of microscopic ENE (ENEmi) and role of adjuvant concurrent...

Independent association of marijuana use and poor oral hygiene with HPV-negative but no...
https://doi.org/10.1002/cncr.33440
Cancer Shewale JB, Pickard RKL et. al.

Feb 23rd, 2021 - Sexual behavior is associated with human papillomavirus (HPV)-positive head and neck cancer, whereas tobacco and alcohol use are associated with HPV-negative cancer. A case-control study was designed to investigate additional demographic and behav...

Significant Declines in Juvenile Onset Recurrent Respiratory Papillomatosis following H...
https://doi.org/10.1093/cid/ciab171
Clinical Infectious Diseases : an Official Publication Of... Meites E, Stone L et. al.

Feb 23rd, 2021 - Juvenile onset recurrent respiratory papillomatosis (JORRP) is a rare and serious disease caused by human papillomavirus (HPV) presumably acquired during vaginal delivery. HPV vaccination of females through age 26 years, recommended in the United ...

Comparing Outcomes for Patients with Human Papillomavirus (HPV) Type 16 versus Other Hi...
https://doi.org/10.1016/j.semarthrit.2020.10.001
Head and Neck Pathology; Shenker RF, May NH et. al.

Feb 22nd, 2021 - The most efficacious strategy to manage pregnant patients with antiphospholipid syndrome (APS) refractory to conventional heparin/low-dose aspirin treatment or at high risk of adverse pregnancy outcomes has not been determined with any degree of c...

Evolution of Public Health Human Papillomavirus Immunization Programs in Canada.
https://doi.org/10.3390/curroncol28010097
Current Oncology (Toronto, Ont.); Goyette A, Yen GP et. al.

Feb 22nd, 2021 - Background: Since 2007, all Canadian provinces and territories have had a publicly funded program for vaccination against human papillomavirus (HPV) infection. The objective of this study was to describe the evolution of these vaccination programs...

see more →

News  1,435 results

HPV Throat Cancer and Oral Sex at Younger Age, Multiple Partners
https://www.medscape.com/viewarticle/943869

Jan 10th, 2021 - Having oral sex with more than 10 previous partners was associated with a 4.3 times' greater likelihood of developing human papillomavirus (HPV)–related oropharyngeal cancer, according to new findings. The study also found that having more partner...

Interventions to Boost HPV Vaccine Uptake Are Cost-Effective
https://www.staging.medscape.com/viewarticle/941063

Nov 16th, 2020 - (Reuters Health) - Interventions in schools and primary care clinics to increase human papillomavirus (HPV) vaccine uptake can be cost-effective, a new analysis suggests. Researchers looked at three different year-long interventions to increase HP...

Interventions to Boost HPV Vaccine Uptake Are Cost-Effective
https://www.medscape.com/viewarticle/941063

Nov 16th, 2020 - (Reuters Health) - Interventions in schools and primary care clinics to increase human papillomavirus (HPV) vaccine uptake can be cost-effective, a new analysis suggests. Researchers looked at three different year-long interventions to increase HP...

Long Lag Time in Anal Pap Follow-up for People With HIV
https://www.medscape.com/viewarticle/941070

Nov 15th, 2020 - It took an average of 380 days for people who had received an abnormal anal Pap test result after having been diagnosed with HIV to undergo high-resolution anoscopy (HRA), which is recommended as follow-up. That delay "revealed missed opportunitie...

Many Black College Students Delay Seeking HPV Vaccination, With Female Students Leading the Trend
https://www.staging.medscape.com/viewarticle/941009

Nov 13th, 2020 - College students from minority communities and communities of color are less likely to receive the human papillomavirus (HPV) vaccine compared with individuals in the White community, with Black women significantly less likely than Black men to pl...

see more →

Patient Education  29 results see all →